Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,090 $ 1,053
Accounts receivable and contract assets, net 192 205
Other current assets 42 45
Total current assets 1,324 1,303
Property and equipment, at cost (note 2) 232 261
Accumulated depreciation (145) (158)
Property and equipment, net 87 103
Intangible assets not subject to amortization (note 4):    
Goodwill 1,387 2,200
Trademarks 522 726
Intangible assets not subject to amortization 1,909 2,926
Intangible assets subject to amortization, net (note 4) 116 112
Other assets 124 194
Total assets 3,560 4,638
Current liabilities:    
Deferred merchant and other payables 265 242
Deferred revenue 49 44
Accrued liabilities and other current liabilities 262 248
Total current liabilities 576 534
Long-term debt, including $287 million and $237 million measured at fair value as of December 31, 2023 and December 31, 2022, respectively (note 5) 1,180 1,125
Deferred income tax liabilities (note 7) 49 120
Financial instrument liabilities (note 3) 21 30
Series A Preferred Stock liability (note 8) 249 230
Other liabilities 253 337
Total liabilities 2,328 2,376
Equity    
Additional paid-in capital 307 287
Accumulated other comprehensive earnings (loss), net of taxes (2) 9
Retained earnings (deficit) (724) (439)
Total stockholders' equity (418) (142)
Noncontrolling interests in equity of subsidiaries 1,650 2,404
Total equity 1,232 2,262
Commitments and contingencies (note 12)
Total liabilities and equity 3,560 4,638
Series A    
Equity    
Common stock value 1 1
Series B    
Equity    
Common stock value
Series C    
Equity    
Common stock value